MPS IIIB

Clinical trials for MPS IIIB explained in plain language.

Never miss a new study

Get alerted when new MPS IIIB trials appear

Sign up with your email to follow new studies for MPS IIIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Hope for sanfilippo kids: Brain-Infused drug enters final testing

Disease control Not yet recruiting

This phase 3 trial tests a drug called tralesinidase alfa in 14 children aged 1-5 with Sanfilippo syndrome type B, a rare genetic disease that causes severe brain damage. The drug is given directly into the brain fluid to replace a missing enzyme. The goal is to see if it can slo…

Matched conditions: MPS IIIB

Phase: PHASE3 • Sponsor: Spruce Biosciences • Aim: Disease control

Last updated Aug 01, 2026 00:00 UTC

MPS IIIB

Get alerted when new MPS IIIB trials appear

Hope for sanfilippo kids: Brain-Infused drug enters final testing